Antibodies anti-Saccharomyces cerevisiae (ASCA) do not differentiate Crohn's disease from celiac disease

Arquivos de Gastroenterologia

Volumn 47, Issue 3, 2010, Pages 242-245

  Kotze, Lorete Maria Da Silva ^a   Nisihara, Renato Mitsunori ^b   Utiyama, Shirley Ramos Da Rosa ^b   Kotze, Paulo Gustavo ^a   Theiss, Petra Mirella ^a   Olandoski, Márcia ^c  

^a HOSPITAL UNIVERSITÁRIO CAJURU   (Brazil)

^b FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Celiac disease; Crohn disease; Diet, gluten free; Saccharomyces cerevisiae

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY;

ADOLESCENT; ADULT; AGED; ARTICLE; CELIAC DISEASE; CONTROLLED STUDY; CROHN DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLUTEN FREE DIET; HUMAN; MAJOR CLINICAL STUDY; MALE; SACCHAROMYCES CEREVISIAE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, FUNGAL; AUTOANTIBODIES; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CELIAC DISEASE; CROHN DISEASE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; SACCHAROMYCES CEREVISIAE; YOUNG ADULT;

EID: 78649957536     PISSN: 00042803     EISSN: 16784219     Source Type: Journal    
DOI: 10.1590/S0004-28032010000300006     Document Type: Article

References (28)

1. Ashorn S, Raukola H, Välineva T, Ashorn M, Wei B, Braun J, Rantala I, Kaukinen K, Luukkaala T, Collin P, Mäki M, Iltanen S. Elevated anti-Saccharomyces cerevisiae, anti-I2 and anti-OmpW antibody levels in patients with suspicion of celiac disease. J Clin Immunol. 2008;28:486-94.
2. Bardella MT, Elli L, De Matteis S, Floriani I, Torri V, Piodi L. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease. Ann Med. 2009;41:139-43.
3. Barta Z, Csipõ I, Szabó GG, Szegedi G. Seroreactivity against Saccharomyces cerevisiae in patients with Crohn's disease and celiac disease. World J Gastroenterol. 2003;9:2308-12.
4. da Rosa Utiyama SR, da Silva Kotze LM, Nisihara RM, Carvalho RF, de Carvalho AG, de Sena MG, de Messias-Reason IJ. Spectrum of autoantibodies in celiac patients and relatives. Dig Dis Sci. 2001;46:2624-30.
5. Damoiseaux JG, Bouten B, Linders AM, Austen J, Roozendaal C, Russel MG, Forget PP, Tervaert JW. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: High prevalence in patients with celiac disease. J Clin Immunol. 2002;22:281-8.
6. Dieterich W, Ehnis T, Bauer M, Donner P, Volta U, Riecken EO, Schuppan D. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat Med. 1997;3:797-801.
7. Fasano A, Shea-Donohue T. Mechanisms of disease: the role of intestinal barrier function in the pathogenesis of gastrointestinal autoimmune disease. Nat Clin Pract Gastroenterol Hepatol. 2005;2:416-22. (Pubitemid 41486094)
8. Giaffer MH, Clark A, Holdsworth CD. Antibodies to Saccharomyces cerevisiae in patients with Crohn's disease and their possible pathogenic importance. Gut. 1992;33:1071-5.
9. Granito A, Zauli D, Muratori P, Muratori L, Grassi A, Bortolotti R, Petrolini N, Veronesi L, Gionchetti P, Bianchi FB, Volta U. Anti-Saccharomyces cerevisiae and perinuclear anti-neutrophil cytoplasmic antibodies in coeliac disease before and after gluten-free diet. Aliment Pharmacol Ther. 2005;21:881-7.
10. Green PHR, Cellier C. Celiac disease. N Engl J Med. 2007;357:1731-43.
11. Harrer M, Reinisch W, Dejaco C, Kratzer V, Gmeiner M, Miehsler W, Norman GL, Gangl A, Vogelsang H. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol. 2003;15:1281-5.
12. Hollander D. Intestinal permeability, leaky gut, and intestinal disorders. Curr Gastroenterol Rep. 1999;1:410-6.
13. Kotze LM, Utiyama SR, Nisihara RM, Zeni MP, de Sena MG, Amarante HM. Antiendomysium antibodies in Brazilian patients with celiac disease and their first-degree relatives. Arq Gastroenterol. 2001;38:94-103.
14. Kotze LM, Nisihara RM, da Rosa Utiyama SR, Piovezan GC, Kotze LR. Thyroid disorders in Brazilian patients with celiac disease. J Clin Gastroenterol. 2006:40:33-6.
15. a. ed. Rio de Janeiro: Guanabara-Koogan;2006. p.332-57.
16. Makharia GK, Sachdev V, Gupta R, Lal S, Pandey RM. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis. Dig Dis Sci. 2007;52:33-9.
17. Mallant-Hent RCh, Mary B, von Blomberg E, Yüksel Z, Wahab PJ, Gundy C, Meyer GA, Mulder CJ. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet. Eur J Gastroenterol Hepatol. 2006;18:75-8.
18. Marsh MN. Mucosal pathology in gluten sensitivity. In: Marsh MN. Coeliac disease. Oxford: Blackwell Scientific Publications; 1992. p.136-91.
19. Mow WS, Vasiliauskas EA, Lin YC, Fleshner PR, Papadakis KA, Taylor KD, Landers CJ, Abreu-Martin MT, Rotter JI, Yang H, Targan SR. Association of antibody responses to microbial antigens and complications of small bowel Crohn's disease. Gastroenterology. 2004;126:414-24. (Pubitemid 38182298)
20. Quinton JF, Sendid B, Reumaux D, Duthilleul P, Cortot A, Grandbastien B, Charrier G, Targan SR, Colombel JF, Poulain D. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic antoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut. 1998;42:788-91.
21. Saibeni S, Folli C, de Franchis R, Borsi G, Vecchi M. Diagnostic role and clinical correlates of anti-Saccaromyces cerevisiae antibodies (ASCA) and anti-neutrophil cytoplasmic antibodies (p-ANCA) in Italian patients with inflammatory bowel diseases. Dig Liver Dis. 2003;35:862-8.
22. Steinwurz F, Scheinberg MA. Diagnóstico sorológico de doença inflamatória intestinal (ASCA e ANCA): avaliaç ão de 70 casos. GED Gastroenterol Endosc Dig. 2001;20:41-2.
23. Toumi D, Mankaï A, Belhadj R, Ghedira-Besbes L, Jeddi M, Ghedira I. Anti-Saccharomyces cerevisiae antibodies in coeliac disease. Scand J Gastroenterol. 2007;42:821-6.
24. van Elburg RM, Uil JJ, Mulder CJ, Heymans HS. Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease. Gut. 1993;34:354-7.
25. Vilela EG, Torres HO, Ferrari ML, Lima AS, Cunha AS. Gut permeability to lactulose and mannitol differs in treated Crohn's disease and celiac disease patients and healthy subjects. Braz J Med Biol Res. 2008;41:1105-9.
26. Vogelsang H, Wyatt J, Penner E, Lochs H. Screening for celiac disease in first-degree relatives of patients with celiac disease by lactulose/mannitol test. Am J Gastroenterol. 1995;90:1838-42.
27. Volta U, Molinaro M, De Franceski I, Fratangelo D, Bianchi FB. IgA class anti-endomysial antibodies on human umbilical cord tissue for celiac disease screening. Save both money and monkeys. Dig Dis Sci. 1995;40:1902-5.
28. World Gastroenterology Organisation Practice Guidelines. Celiac disease [on-line]. World Gastroenterology Organisation; 2007. Available from: worldgastroenterology.org/celiac-disease.html.